Apogee Therapeutics (NASDAQ:APGE) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Apogee Therapeutics (APGE) operate in?

Apogee Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Apogee Therapeutics Stock (NASDAQ: APGE) stock price, news, charts, stock research, profile.

Open	$45.26
Close	-
Volume / Avg.	20.69K / 402.64K
Day Range	$44.02 - $46.37
52 Wk Range	16.39 - 72.29
Market Cap	$2.49B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	17.61%
Days to Cover	26.25

Recent News

XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details

10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit Therapeutics, Plug Power and XPeng Inc.

Lekha Gupta

Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

Top 3 Health Care Stocks That Are Ticking Portfolio Bombs

As of March 14, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$45.26
Close	-
Volume / Avg.	20.69K / 402.64K
Day Range	$44.02 - $46.37
52 Wk Range	16.39 - 72.29
Market Cap	$2.49B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	17.61%
Days to Cover	26.25

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Apogee Therapeutics (APGE) stock?

You can purchase shares of Apogee Therapeutics (NASDAQ:APGE) through any online brokerage.

View our list of the best stock brokerages

Who are Apogee Therapeutics (APGE) competitors?

Other companies in Apogee Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Centessa Pharmaceuticals (NASDAQ:CNTA), SpringWorks Therapeutics (NASDAQ:SWTX) and Protagonist Therapeutics (NASDAQ:PTGX).

What is the forecast, or price target, for Apogee Therapeutics (APGE) stock?

Apogee Therapeutics has a consensus price target of $78.50.

What is the current price for Apogee Therapeutics (APGE)?

The stock price for Apogee Therapeutics (NASDAQ: APGE) is $43.84 last updated November 21, 2024 at 10:08 AM EST.

Does Apogee Therapeutics (APGE) pay a dividend?

There are no upcoming dividends for Apogee Therapeutics.

When is Apogee Therapeutics (NASDAQ:APGE) reporting earnings?

Apogee Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Apogee Therapeutics (APGE) going to split?

There is no upcoming split for Apogee Therapeutics.

What sector and industry does Apogee Therapeutics (APGE) operate in?

Apogee Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Apogee Therapeutics

Apogee Therapeutics (APGE) Forecast